Stryker (Stryker) 3-Year Revenue Growth Rate

: 12.30% (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

Stryker's Revenue per Share for the three months ended in Dec. 2023 was $15.16.

During the past 12 months, Stryker's average Revenue per Share Growth Rate was 10.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 8.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Stryker was 32.90% per year. The lowest was 4.80% per year. And the median was 12.40% per year.

Competitive Comparison

For the Medical Devices subindustry, Stryker's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stryker 3-Year Revenue Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Stryker's 3-Year Revenue Growth Rate falls into.

Stryker 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Stryker (NYSE:SYK) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Stryker 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Stryker's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker (Stryker) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

SYK:Mexico 1SYK:Italy SYK:Germany SYK:Germany S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Executives

Srikant Datar	director	ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
Berry William E Jr	officer: Vice President, Controller	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo	officer: Group Pres., Neurotech & Spine	STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston	director	2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher	officer: VP, Chief Legal Officer	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
James Andrew Pierce	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein	officer: Vice President, CFO	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink	officer: VP, Global Human Resources	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio	director	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell	officer: Group President	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen	officer: VP	2825 AIRVIEW BLVD., KALAMAZOO MI 49002